9G2.SI SES
Singapore Institute of Advanced Medicine Holdings Ltd.
1W: +0.0%
1M: -6.7%
3M: -3.5%
YTD: -47.2%
1Y: -3.5%
S$0.03 ($0.02)
+0.00 (+0.00%)
Weekly Expected Move ±8.9%
S$0
S$0
S$0
S$0
S$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$125M
-10.1% ▼
4Y CAGR: -7.7%
Total Liabilities
$69M
+21.2% ▲
4Y CAGR: -11.6%
Shareholders Equity
$56M
-31.9% ▼
4Y CAGR: -1.5%
Cash & Investments
$3M
-10.1% ▼
4Y CAGR: -27.5%
Total Debt
$58M
+26.3% ▲
4Y CAGR: -10.9%
Net Debt
$55M
+29.0% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $10M | $16M | $11M | $3M | $3M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $10M | $16M | $11M | $3M | $3M |
| Net Receivables | $2M | $4M | $2M | $1M | $2M |
| Inventory | $110K | $97K | $106K | $103K | $115K |
| Other Current Assets | $0 | $1 | $0 | $44K | $761K |
| Total Current Assets | $14M | $21M | $13M | $5M | $5M |
| Property, Plant & Equip. | $141M | $138M | $142M | $130M | $116M |
| Goodwill & Intangibles | $21K | $36K | $27K | $18K | $8K |
| Long-Term Investments | $14M | $12M | $500K | $0 | $0 |
| Other Non-Current Assets | $3M | $3M | $3M | $4M | $3M |
| Total Non-Current Assets | $158M | $154M | $146M | $134M | $119M |
| Total Assets | $172M | $174M | $160M | $139M | $125M |
| — Liabilities — | |||||
| Accounts Payable | $544K | $458K | $762K | $754K | $6M |
| Short-Term Debt | $13M | $19M | $27M | $4M | $9M |
| Deferred Revenue | $20K | $24K | $253K | $0 | $0 |
| Other Current Liabilities | $16M | $28M | $25M | $5M | $0 |
| Total Current Liabilities | $32M | $50M | $53M | $13M | $17M |
| Long-Term Debt | $39M | $30M | $21M | $10M | $19M |
| Other Non-Current Liab. | $4M | $4M | $8M | $5M | $5M |
| Total Non-Current Liabilities | $81M | $70M | $62M | $44M | $52M |
| Total Liabilities | $113M | $120M | $115M | $57M | $69M |
| — Equity — | |||||
| Common Stock | $83M | $103M | $105M | $191M | $191M |
| Retained Earnings | -$36M | -$48M | -$66M | -$104M | -$130M |
| Accumulated OCI | $12M | -$322K | $6M | $0 | -$6M |
| Total Stockholders Equity | $59M | $54M | $45M | $82M | $56M |
| Total Liabilities & Equity | $172M | $174M | $160M | $139M | $125M |
| — Key Metrics — | |||||
| Total Debt | $92M | $87M | $81M | $46M | $58M |
| Net Debt | $82M | $71M | $70M | $43M | $55M |
| Total Investments | $14M | $12M | $500K | $0 | $0 |